Cargando…
The progress of molecules and strategies for the treatment of HBV infection
Hepatitis B virus infections have always been associated with high levels of mortality. In 2019, hepatitis B virus (HBV)-related diseases resulted in approximately 555,000 deaths globally. In view of its high lethality, the treatment of HBV infections has always presented a huge challenge. The World...
Autores principales: | Pan, Youlu, Xia, Heye, He, Yanwen, Zeng, Shenxin, Shen, Zhengrong, Huang, Wenhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053227/ https://www.ncbi.nlm.nih.gov/pubmed/37009498 http://dx.doi.org/10.3389/fcimb.2023.1128807 |
Ejemplares similares
-
Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
por: Yang, Fangji, et al.
Publicado: (2019) -
HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors
por: Shen, Jiaming, et al.
Publicado: (2023) -
High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable
por: Wang, Chengwei, et al.
Publicado: (2023) -
Association of genetic polymorphisms in the
C19orf66
gene and biochemical indices of HBV infected individuals in Yunnan
por: Liu, Ni, et al.
Publicado: (2023) -
Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer
por: Wang, Xueke, et al.
Publicado: (2021)